Skip to main content

Healthy Subjects

294
Pipeline Programs
30
Companies
32
Clinical Trials
4 recruiting
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
279
3
4
0
6
2
Early DiscoveryClinical DevelopmentMarket

Drug Modality Breakdown

Small Molecule
3578%
Peptide
613%
Vaccine
37%
Monoclonal Antibody
12%
+ 390 programs with unclassified modality

Competitive Landscape

109 companies ranked by most advanced pipeline stage

Pfizer
PfizerNEW YORK, NY
37 programs
33
1
1
1
7-pneumococcal conjugate vaccinePhase 4Vaccine1 trial
13-valent pneumococcal conjugate vaccinePhase 3Vaccine1 trial
13-Valent Pneumococcal Conjugate VaccinePhase 1/2Vaccine1 trial
AGG-523Phase 11 trial
ApixabanPhase 1
+32 more programs
Active Trials
NCT00768833Completed242Est. Aug 2014
NCT00380900CompletedEst. Feb 2007
NCT00894439Completed24Est. Jul 2009
+44 more trials
Ache Laboratorios Farmaceuticos
1
SomatropinPhase 41 trial
Active Trials
NCT03634514Unknown68Est. Oct 2018
ViiV Healthcare
45 programs
40
2
2
GSK1755165; placebo; zopiclonePhase 3
Sodium fluoride toothpastePhase 3
0.12% chlorhexidine mouthrinsePhase 2
GW856553Phase 2
Dolutegravir 50 mg/abacavir 600 mg/lamivudine 300 mgPhase 1
+40 more programs
Abbott
AbbottABBOTT PARK, IL
3 programs
2
1
Study product containing luteinPhase 31 trial
CortimentPhase 11 trial
SLV337 suspensionPhase 11 trial
Active Trials
NCT05519514Completed56Est. Nov 2021
NCT01176201Completed12Est. Oct 2010
NCT01730898Completed24Est. Mar 2013
NicOx
1 program
1
AC-170 0.24%Phase 31 trial
Active Trials
NCT02756624Completed516Est. Aug 2016
Bayer
BayerLEVERKUSEN, Germany
1 program
1
Acetylsalicyclic acidPhase 31 trial
Active Trials
NCT01420094Completed510Est. Sep 2011
Cerus
2 programs
2
INTERCEPT Blood System for Platelets with LED IlluminatorPhase 21 trial
INTERCEPT Blood System for RBCsPhase 21 trial
Active Trials
NCT06697223Completed40Est. Jun 2025
NCT07015437Recruiting70Est. Oct 2026
Astellas
29 programs
28
1
ASP8232Phase 1/21 trial
ASP015KPhase 11 trial
ASP015KPhase 11 trial
ASP015KPhase 11 trial
ASP015KPhase 11 trial
+24 more programs
Active Trials
NCT01364974Completed48Est. May 2009
NCT01387087Completed72Est. Nov 2008
NCT01959399Completed24Est. Jul 2013
+29 more trials
AbbVie
AbbVieNORTH CHICAGO, IL
1 program
1
MAP0004Phase 1/21 trial
Active Trials
NCT01199965Completed47Est. Apr 2010
Idorsia
28 programs
28
14C-radiolabeled ACT-132577Phase 11 trial
AC-082Phase 11 trial
AC-083Phase 11 trial
AC-084Phase 11 trial
ACT-129968 500 mg tabletPhase 11 trial
+23 more programs
Active Trials
NCT03100591Completed6Est. Apr 2017
NCT02702648Completed128Est. Mar 2017
NCT02719197Completed72Est. Dec 2016
+24 more trials
Biocorp
21 programs
21
ASP1517Phase 11 trial
ASP1517Phase 11 trial
CapScanPhase 11 trial
Dapagliflozin-Test productPhase 11 trial
Desogestrel-Test productPhase 11 trial
+16 more programs
Active Trials
NCT02805374Completed16Est. Aug 2016
NCT02952040Completed18Est. Dec 2016
NCT07054593Not Yet Recruiting44Est. Jul 2026
+18 more trials
Innova Therapeutics
16
Dapagliflozin-Test productPhase 1
Desogestrel-Test productPhase 1
Drospirenone+ Ethinyl Estradiol Tablets-Test productPhase 1
Drospirenone+ Ethinyl Estradiol Tablets-Test productPhase 1
Dutasteride-Test productPhase 1
+11 more programs
AstraZeneca
AstraZenecaCAMBRIDGE, United Kingdom
14 programs
14
ALXN1007Phase 11 trial
AZD1979Phase 11 trial
AZD7295Phase 11 trial
AZD7798Phase 11 trial
AZD7986Phase 11 trial
+9 more programs
Active Trials
NCT01883544Completed16Est. Jan 2014
NCT02072993Terminated116Est. Jul 2014
NCT00818129Completed62Est. May 2009
+9 more trials
Innovation Pharmaceuticals
9
AC-076 for s.c. administrationPhase 11 trial
ACT-246475Phase 11 trial
ACT-334441 2 mgPhase 11 trial
CenerimodPhase 11 trial
CenerimodPhase 11 trial
+5 more programs
Active Trials
NCT04301973Completed18Est. Jan 2021
NCT03173625Completed72Est. Apr 2017
NCT03593278Completed6Est. Aug 2018
+6 more trials
Innovent Biologics
6
IBI112 dose1Phase 11 trial
IBI351Phase 11 trial
IBI353Phase 11 trial
IpilimumabPhase 1Monoclonal Antibody1 trial
ItraconazolePhase 1Small Molecule1 trial
+1 more programs
Active Trials
NCT04511624Completed46Est. Jul 2022
NCT05688124Completed24Est. Oct 2023
NCT05490316Completed20Est. Dec 2022
+3 more trials
Shionogi
5 programs
5
Dolutegravir 50 mg/abacavir 600 mg/lamivudine 300 mgPhase 1
GSK1349572Phase 1
GSK1349572Phase 1
GSK1349572Phase 1
GSK1349572 250 mgPhase 1
Human BioSciences
2
EC5026 oral tabletPhase 1
KB15A Vaginal FilmPhase 1
CIRCAdian Rhythm of the IMMune Age IndeX (IMMAX)N/A1 trial
Presence - Perspective - AffectN/A1 trial
Active Trials
NCT07169721Completed50Est. Apr 2024
NCT01833104Completed332Est. Feb 2016
Purdue Pharma
4 programs
3
LEM5Phase 1
LemborexantPhase 1
lemborexantPhase 1
Transcutaneous Auricular Vagus Nerve StimulationN/A1 trial
Active Trials
NCT04206540Active Not Recruiting30Est. Aug 2027
Abbisko Therapeutics
4
ABSK021Phase 15 trials
Part A ABSK201 and ItraconazolePhase 1Small Molecule1 trial
[14C]ABSK011Phase 11 trial
[14C]ABSK011Phase 1
Active Trials
NCT06322706Completed36Est. Nov 2024
NCT06186583Completed6Est. Jul 2024
NCT06111274Recruiting82Est. Dec 2026
+4 more trials
Prevail Therapeutics
3
ExenatidePhase 1Peptide1 trial
LY2140023Phase 11 trial
exenatidePhase 1Peptide1 trial
Active Trials
NCT01297062Completed94Est. May 2011
NCT01440478Completed30Est. Oct 2011
NCT00672399Completed70Est. Jul 2008
BioTherapeutics Inc
3
Experimental: TAVO101Phase 11 trial
NBL-012 InjectionPhase 1
TAVO103APhase 11 trial
Active Trials
NCT05298046Completed42Est. Sep 2024
NCT05313152Completed30Est. Jun 2023
Puma Biotechnology
3
NeratinibPhase 1Small Molecule1 trial
neratinibPhase 1Small Molecule1 trial
neratinibPhase 1Small Molecule1 trial
Active Trials
NCT00864487Completed24Est. May 2009
NCT00757809Completed50Est. Oct 2008
NCT00814060Completed24Est. Mar 2009
Quotient Therapeutics
3
Quizartinib dihydrochloridePhase 11 trial
UproleselanPhase 11 trial
pracinostatPhase 1Small Molecule1 trial
Active Trials
NCT04796831Completed8Est. Jun 2021
NCT03606447Completed5Est. Sep 2018
NCT03495934Completed6Est. Feb 2018
Dizal Pharma
2 programs
2
AZD4205 and carbamazepinePhase 11 trial
DZD9008 and intraconazolePhase 1Small Molecule1 trial
Active Trials
NCT05486949Completed32Est. Oct 2022
NCT05418582Completed40Est. Dec 2022
Chong Kun Dang Pharmaceutical
2
CKD-508 CapsulePhase 11 trial
CKD-508 TabletPhase 11 trial
Active Trials
NCT04488900Completed88Est. Jul 2023
NCT06727396Completed44Est. Jun 2025
Tavotek Biotherapeutics
2
Experimental: TAVO101Phase 1
TAVO103APhase 1
Sunshine Biopharma
2
HEC-007 injectionPhase 11 trial
Midazolam SyrupPhase 11 trial
Active Trials
NCT07102251Recruiting126Est. Dec 2026
NCT05504876Completed14Est. Dec 2022
Minerva Neurosciences
2
MIN-101Phase 11 trial
MIN-101Phase 11 trial
Active Trials
NCT03072056Completed23Est. Jul 2017
NCT03038646Completed14Est. Apr 2017
Tanabe Pharma America
2
MT-7117Phase 11 trial
MT-7117Phase 11 trial
Active Trials
NCT05241535Completed29Est. Feb 2022
NCT04793295Completed112Est. Feb 2022
Servier
2 programs
2
OSE-127Phase 1
Vorasidenib 40 mg Oral TabletPhase 1

+79 more companies

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
2027
2028
2029
Pfizeractive
Pfizeractive
Ache Laboratorios FarmaceuticosSomatropin
Pfizerpharmacokinetic
UCB PharmaLevetiracetam 250 mg
Pfizer7-pneumococcal conjugate vaccine
Pfizerpharmacokinetic
Pfizeractive
AstellasASP5354
BiogenBIIB059
AstellasASP5354
Abbisko TherapeuticsABSK021
Pfizeractive
Pfizeractive
NicOxAC-170 0.24%

Showing 15 of 32 trials with date data

Clinical Trials (32)

Total enrollment: 7,041 patients across 32 trials

ToFAcitinib in Early Active Axial SpondyloarThritis:

Start: Nov 2023Est. completion: Jun 2026104 patients
Phase 4Recruiting

Actigraphy Improvement With Voxelotor (ActIVe) Study

Start: Dec 2020Est. completion: Sep 202225 patients
Phase 4Completed

Non-inferiority Evaluation of Pain Intensity After Biomatrop (Somatropin) Application in Relation to Hormotrop (Somatropin), in Healthy Subjects

Start: Aug 2018Est. completion: Oct 201868 patients
Phase 4Unknown
NCT02101554Pfizerpharmacokinetic

Safety and Pharmacokinetic Study of EMBEDA in Children Ages 7-17 With Pain

Start: Apr 2015Est. completion: Jun 201919 patients
Phase 4Terminated
NCT01491113UCB PharmaLevetiracetam 250 mg

Pharmacokinetic (PK) Study in Japanese Non-epileptic Renal Impaired Patients

Start: Nov 2011Est. completion: Nov 201230 patients
Phase 4Completed
NCT01250756Pfizer7-pneumococcal conjugate vaccine

A Trial Evaluating a 7-valent Pneumococcal Conjugate Vaccine Given With Diphtheria, Tetanus, and Acellular Pertussis Vaccine (DTaP) in Healthy Japanese Infants.

Start: Nov 2010Est. completion: Mar 2012321 patients
Phase 4Completed
NCT00952653Pfizerpharmacokinetic

Study Evaluating the Effect of Desvenlafaxine on the Pharmacokinetics of Midazolam

Start: Jun 2010Est. completion: Aug 201028 patients
Phase 4Completed

Study Comparing Enbrel (Etanercept) Plus Methotrexate Versus Enbrel Alone in Active Rheumatoid Arthritis Despite Current Methotrexate Therapy

Start: Mar 2003Est. completion: May 2004300 patients
Phase 4Completed

A Study to Find Out if ASP5354 Can Clearly Help Show the Ureter During Surgery in People With or Without Kidney Disease

Start: Mar 2024Est. completion: Oct 202595 patients
Phase 3Completed

A Long-Term Extension Study to Learn More About the Safety of Litifilimab (BIIB059) Injections and Whether They Can Improve Symptoms of Adult Participants Who Have Active Cutaneous Lupus Erythematosus

Start: Oct 2023Est. completion: Dec 2029322 patients
Phase 3Enrolling By Invitation

A Study to Find Out if ASP5354 Can Clearly Help Show the Ureter During Surgery

Start: Aug 2023Est. completion: Jan 2025107 patients
Phase 3Completed

Study of Pimicotinib (ABSK021) for Tenosynovial Giant Cell Tumor (MANEUVER)

Start: Apr 2023Est. completion: Jun 202894 patients
Phase 3Active Not Recruiting

An Extension Study for Treatment of Moderately to Severely Active Ulcerative Colitis

Start: Sep 2019Est. completion: Jun 2029896 patients
Phase 3Active Not Recruiting

Efficacy and Safety of Tofacitinib in Subjects With Active Ankylosing Spondylitis (AS)

Start: Jun 2018Est. completion: Aug 2020270 patients
Phase 3Completed
NCT02756624NicOxAC-170 0.24%

A Multi-Center, Vehicle-Controlled, Parallel-Group Study Evaluating the Safety of AC-170 Ophthalmic Solution

Start: Apr 2016Est. completion: Aug 2016516 patients
Phase 3Completed
NCT01730898AbbottStudy product containing lutein

Lutein Absorption in Healthy Adults

Start: Nov 2012Est. completion: Mar 201324 patients
Phase 3Completed
NCT01590368ConvaTecMarketed electrode

A Comparative Wear Test of Two Adhesives on the Unilect ™ Biotab Short Term Monitoring Electrode

Start: Jun 2012Est. completion: Jun 201220 patients
Phase 3Unknown

Aggressive Cholesterol Therapy to Inhibit Vein Graft Events After CABG (ACTIVE Trial)

Start: Mar 2012Est. completion: Jan 2017173 patients
Phase 3Completed

TR-701 FA vs Linezolid for the Treatment of Acute Bacterial Skin and Skin Structure Infections

Start: Sep 2011Est. completion: Jan 2013666 patients
Phase 3Completed
NCT01420094BayerAcetylsalicyclic acid

Evaluate Onset of Action of a Fast Release Aspirin

Start: Jun 2011Est. completion: Sep 2011510 patients
Phase 3Completed
NCT01103713Pfizerpharmacokinetic

Evaluate Parasitological Clearance Rates And Pharmacokinetics Of The Combination Of Azithromycin And Chloroquine In Asymptomatic Pregnant Women With Falciparum Parasitemia In Africa

Start: Mar 2011Est. completion: Oct 2013168 patients
Phase 3Terminated
NCT01200368Pfizer13-valent pneumococcal conjugate vaccine

Trial Evaluating a 13-valent Pneumococcal Conjugate Vaccine Given With Diphtheria, Tetanus, and Acellular Pertussis Vaccine (DTaP) in Healthy Japanese Infants

Start: Sep 2010Est. completion: Nov 2011551 patients
Phase 3Completed

TR-701 FA vs. Linezolid for the Treatment of Acute Bacterial Skin and Skin Structure Infections.

Start: Aug 2010Est. completion: Sep 2011667 patients
Phase 3Completed
NCT00761267Pfizerpharmacokinetic

Study To Assess Pharmacokinetics, Safety & Efficacy of Anidulafungin When Treating Children With Invasive Candidiasis

Start: Feb 2009Est. completion: Feb 201870 patients
Phase 3Completed
NCT00329186Pfizerpharmacokinetic

Study Evaluating the Pharmacokinetics of Venlafaxine ER and Desvenlafaxine SR in Healthy Subjects

Start: May 2006Est. completion: Jun 200714 patients
Phase 3Completed

A Study to Evaluate the Efficacy of Tolterodine Prolonged Release Compared With Propiverine for the Treatment of Korean Patients With Overactive Bladder as Assessed by Ambulatory Urodynamic Monitoring

Start: Mar 2003Est. completion: Aug 200341 patients
Phase 3Completed
NCT00240747Pfizerpharmacokinetic

Open-label, Multiple-dose, Phase III Study of the Population Pharmacokinetics of I.V. Synercid in 75 Pediatric Patients

Start: Jun 2000Est. completion: Jan 2005
Phase 3Terminated

Study Evaluating TMI-005 in Active Rheumatoid Arthritis

Est. completion: Aug 2005390 patients
Phase 2Completed

A Study to Evaluate TNX-102 SL Monotherapy Versus Placebo in Participants With Major Depressive Disorder (MDD)

Start: Jun 2026Est. completion: Feb 2028360 patients
Phase 2Recruiting
NCT07015437CerusINTERCEPT Blood System for RBCs

A Recovery and Lifespan Study Using INTERCEPT Red Blood Cells Prepared Using the INTERCEPT Blood System for RBCs With AS-1

Start: Sep 2025Est. completion: Oct 202670 patients
Phase 2Recruiting
NCT06697223CerusINTERCEPT Blood System for Platelets with LED Illuminator

A Study to Assess Recovery and Survival of Radiolabeled Apheresis Platelet Components Treated With the INTERCEPT Blood System for Platelets With LED Illuminator.

Start: Jan 2025Est. completion: Jun 202540 patients
Phase 2Completed

A Phase 2 Study of ABSK021 in Patients With Advanced Pancreatic Cancer

Start: Oct 2023Est. completion: Dec 202682 patients
Phase 2Recruiting

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

6 late-stage (Phase 3) programs, potential near-term approvals
4 actively recruiting trials targeting 7,041 patients
30 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.